// App-Quantinova.ai

3110 : Prognostic Impact of Recipient and Donor CMV Serostatus in Acute Leukemia Patients After Allogeneic Stem Cell Transplantation At the Era of Preemptive Therapy.

Researchers

Presenter

  • Myriam Labopin

Principal Investigators

  • Dietrich Beelen

  • Ulrike Feldmann

  • Carlheinz Muller

  • Emanuelle Polge

  • Igor Wolfgang Blau

  • Mohamad Mohty

  • Liisa Volin

  • Gerhard Ehninger

  • Jurgen Finke

  • Gerard Socie

  • Rainer Schwerdtfeger

  • Nicolaus Kroger

  • Arnold Ganser

  • Dietger Niederwieser

Medical Centers

  • Department of Hematology/Oncology, Goethe-University Hospital Frankfurt, Frankfurt Am Main, Germany

  • Labor Berlin, Division of Hematology, Oncology, Charite University Berlin, Berlin, Germany

  • Center of Bone Marrow Transplantation, Wiesbaden, Germany

  • University of Leipzig, Leipzig, Germany

  • DRST Data Office, Ulm, Germany

  • Hematology, Oncology, and Tumor Immunology, HELIOS Klinikum Berlin-Buch, Berlin, Germany

  • Center of Oncology - Department of Stem Cell Transplantation, UNIVERSITY MEDICAL CENTER Hamburg Eppendorf, Hamburg, Germany

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • Helsinki University Central Hospital Cancer Center, Helsinki, Finland

  • Hematology and Bone Marrow Transplantation, Saint-Louis Hospital, Paris, France,

  • Hematology, Hospital Saint Antoine, Paris, France,

  • EBMT Acute Leukemia Working Party and Registry, Paris, France

  • Medical Clinic I, Division of Hematology, University Hospital Dresden, Dresden, Germany

Locations

  • Finland

  • Germany

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Acute lymphoblastic leukemia

  • Myeloid neoplasms

  • Graft-versus-host disease

  • Acute myelocytic leukemia

  • Cytomegalovirus infection

  • Acute Leukemia

  • Pulmonary alveolar proteinosis

Biomarkers

  • Breakpoint Cluster Region

  • Estrogen receptor alpha

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved